Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada’s federal correctional system
- DOI
- 10.17269/s41997-026-01186-x
- Published
- 2026-04-09
- Container
- Canadian Journal of Public Health
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.17269/s41997-026-01186-x,
title = {Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada’s federal correctional system},
author = {Cayley Russell and Tony P. George and Nitin Chopra and Bernard Le Foll and Flora I. Matheson and Gillian Kolla and Jennifer Wyman and Benedikt Fischer and Nikki Bozinoff and Jürgen Rehm and Shannon Lange},
year = {2026},
journal = {Canadian Journal of Public Health},
doi = {10.17269/s41997-026-01186-x},
url = {https://doi.org/10.17269/s41997-026-01186-x}
}RIS
TY - JOUR TI - Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada’s federal correctional system AU - Cayley Russell AU - Tony P. George AU - Nitin Chopra AU - Bernard Le Foll AU - Flora I. Matheson AU - Gillian Kolla AU - Jennifer Wyman AU - Benedikt Fischer AU - Nikki Bozinoff AU - Jürgen Rehm AU - Shannon Lange PY - 2026 JO - Canadian Journal of Public Health DO - 10.17269/s41997-026-01186-x UR - https://doi.org/10.17269/s41997-026-01186-x ER -
APA
Russell, C., George, T. P., Chopra, N., Foll, B. L., Matheson, F. I., Kolla, G., Wyman, J., Fischer, B., Bozinoff, N., Rehm, J., & Lange, S. (2026). Clarifying the evidence and implications of prioritizing extended-release buprenorphine for opioid agonist treatment in Canada’s federal correctional system. Canadian Journal of Public Health. https://doi.org/10.17269/s41997-026-01186-x
Source records
- crossref · retrieved 2026-09-27T14:04:33.262Z